| abstract |
(57) [Summary] [Object] To provide a combined therapeutic method capable of significantly enhancing the therapeutic effect in the treatment of diseases using interferon, particularly in the treatment of viral hepatitis, and a pharmaceutical used for the combined treatment. [Structure] In the treatment of a disease susceptible to treatment with human interferon, in combination with the use of human interferon, a free radical scavenger (particularly reduced glutathione) or its precursor or inducer (particularly N-acetyl) is used. Cysteine) is used. |